| Biological activities of siRNA-loaded lanthanum phosphate nanoparticles on colorectal cancer PP Li, Y Yan, HT Zhang, S Cui, CH Wang, W Wei, HG Qian, JC Wang, ... Journal of controlled release 328, 45-58, 2020 | 11 | 2020 |
| Changes in racial and ethnic disparities in glucose‐lowering drug utilization and glycated haemoglobin A1c in US adults with diabetes: 2005‐2018 P Li, P Zhang, D Guan, J Guo, Y Zhang, ME Pavkov, KMK Bullard, H Shao Diabetes, Obesity and Metabolism 25 (2), 516-525, 2023 | 4 | 2023 |
| Socioeconomic Factors Play a More Important Role than Clinical Needs in the Use of SGLT2 Inhibitors and GLP-1 Receptor Agonists in People With Type 2 Diabetes. H Shao, P Li, J Guo, V Fonseca, L Shi, P Zhang Diabetes Care 45 (2), 2022 | 4 | 2022 |
| 1262-P: developing a computable phenotype algorithm for identification of children and adolescents with diabetes using electronic health records P Li, E Spector, K Alkhuzam, RS Patel, WT Donahoo, S Bost, T Lyu, Y Wu, ... Diabetes 71 (Supplement_1), 2022 | 3 | 2022 |
| Efficacy of iGlarLixi on 5-year risk of diabetes-related complications: a simulation study H Shao, H Kianmehr, J Guo, P Li, V Fonseca, L Shi Journal of Diabetes and its Complications 36 (3), 108132, 2022 | 3 | 2022 |
| Association between Antidepressants and Dementia Risk in Older Adults with Depression: A Systematic Review and Meta-Analysis GHM Wang, P Li, Y Wang, J Guo, DL Wilson, WH Lo-Ciganic Journal of Clinical Medicine 12 (19), 6342, 2023 | 2 | 2023 |
| 1265-P: the role of health system penetration rate in estimating prevalence of type 1 diabetes (T1D) in children and adolescents using electronic health records (EHR) P Li, T Lyu, J Bian, Y Guo, E Shenkman, WT Donahoo, J Guo, H Shao Diabetes 71 (Supplement_1), 2022 | 2 | 2022 |
| Treatment of cervical cancer by siRNA-loaded chitosan-coated calcium phosphate nanoparticles P Li, Y Yan, H Zhang, R Wang, H Han, J Wang Journal of Chinese Pharmaceutical Sciences 27 (8), 517, 2018 | 2 | 2018 |
| 810-P: The Diminishing Cost-Effectiveness of the Newer Glucose-Lowering Drugs in the United States, 2010-2018 P Li, RS Patel, SM Vouri, L Shi, V Fonseca, H Shao Diabetes 70 (Supplement_1), 2021 | 1 | 2021 |
| Some patients with type 2 diabetes may benefit from intensive glycaemic and blood pressure control: A post‐hoc machine learning analysis of ACCORD trial data T Jiao, H Kianmehr, Y Lin, P Li, N Singh Ospina, HK Ghayee, M Ruzieh, ... Diabetes, Obesity and Metabolism, 2024 | | 2024 |
| The role of health system penetration rate in estimating the prevalence of type 1 diabetes in children and adolescents using electronic health records P Li, T Lyu, K Alkhuzam, E Spector, WT Donahoo, S Bost, Y Wu, ... Journal of the American Medical Informatics Association 31 (1), 165-173, 2024 | | 2024 |
| Incremental burden on health‐related quality of life, health service utilization and direct medical expenditures associated with cognitive impairment among non … D Guan, MO Lewis, P Li, Y Zhang, P Zhang, S Tang, J Brown, J Guo, ... Diabetes, Obesity and Metabolism 26 (1), 275-282, 2024 | | 2024 |
| 1455-P: Developing Computable Phenotypes (CPs) for Identifying Children, Adolescents, and Young Adults with Diabetes Using Electronic Health Records in the DiCAYA Network HUI SHAO, YI GUO, J BIAN, P LI, D DABELEA, RB CONWAY, TL CRUME, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 1006-P: Distributional Cost-Effectiveness Analysis of Glucagon-Like Peptide-1 Receptor Agonists (GLP-1 RA) and Tirzepatide Compared with Sulfonylureas (SU) in People with … P LI, D GUAN, MK ALI, KM VENKAT NARAYAN, V FONSECA, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| 1005-P: Developing a Machine-Learning–Based Prediction Model for Diabetes Duration Using Information from Electronic Health Records D GUAN, P LI, V FONSECA, L SHI, MK ALI, J SAM VARGHESE, ... Diabetes 72 (Supplement_1), 2023 | | 2023 |
| EE189 CAPOX versus mFOLFOX as Adjuvant Chemotherapy in Patients with Stage 3 Colon Cancer: A Cost-Effectiveness Study S Abuloha, P Li, J Bian, Y Guo, H Shao Value in Health 25 (7), S370, 2022 | | 2022 |
| 951-P: Racial and Ethnic Disparities in Diabetes Management, Hospitalization Risk, and Physical Health Status Associated with Cognitive Impairment among Older Adults with Diabetes P Li, P Zhang, S Tang, J Guo, JD Brown, T Jiao, H Shao Diabetes 71 (Supplement_1), 2022 | | 2022 |
| The diminishing cost-effectiveness of the newer glucose-lowering drug classes in the United States: 2010–2018 P Li, R Patel, J Guo, SM Vouri, L Shi, V Fonseca, H Shao Current Medical Research and Opinion 37 (11), 1875-1880, 2021 | | 2021 |
| A varied approach to left ventricular assist device follow-up improves cost-effectiveness MM Ahmed, P Li, LE Meece, J Bian, H Shao Current Medical Research and Opinion 37 (9), 1501-1505, 2021 | | 2021 |
| 364-P: Efficacy of IGlarLixi on Five-Year Risk of Diabetes-Related Complications: A Simulation Experiment HUI SHAO, H KIANMEHR, P LI, V FONSECA, L SHI Diabetes 70 (Supplement_1), 2021 | | 2021 |
